Engaging Innovation | Friends of Cancer Research

Engaging Innovation

Featured Post

March 14, 2019

Data Driven: How Oncologists Perceive FDA-Approved Drug Labeling Compared to Other Major Prescribing Resources

Physicians rely on a variety of sources of information to provide high-quality care to patients. In oncology, some of the most prominent resources that inform provider decision-making are the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) clinical practice guidelines; drug compendia; electronic point-of-care decision...
More Posts

Recent Posts

No Results With Current Filter Choices

A Blueprint for Breakthrough: Research and Reimbursement in the Age of Precision Medicine

  Next-generation sequencing (NGS) is becoming a commonly used tool in cancer treatment. Transparency regarding the clinical performance and utility of different NGS-based tests available will aid in clinical decision-making and facilitate improvements in patient care.  The 7th Annual Blueprint for Breakthrough Forum, held by Friends of Cancer Research (Friends) and...

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To...

The Magic of Summer at Camp Fantastic

With summer now behind us, we thought it would be a good time to reflect on one of the special experiences our science policy analyst, Diana Merino, had over the summer...   This summer, for the second year in a row, I got to spend a week volunteering at Camp Fantastic, a...

Keeping Patients at the Forefront of Our Work

I was 18 when my life was turned upside down by cancer. My mother was diagnosed with a highly aggressive malignancy after a colonoscopy due to a flair-up of Crohn’s disease. She spent the next two months in the hospital after the surgery to remove the malignancy left her near...

Tough as Hell – A Breast Cancer Fighter Tells Her Story

In November 2014, assistant professor, Jenna Kieckhaefer, was diagnosed with breast cancer. She was only 28 years old at the time.     The concept of having breast cancer first came to Jenna’s attention when she was working on her PhD. She went for an annual visit and was informed she had lumpy...

David Baltimore Talks Cancer, Research, and How Things Have Changed Since He Was in High School

David Baltimore is a world-renowned biologist who in 1975 won the Nobel Prize in physiology or medicine along with Howard Temin and Renato Dulbecco “for their discoveries concerning the interaction between tumor viruses and the genetic material of the cell.” We had the chance to sit down and discuss science,...

My Story: Jeff Allen

In the second installment of the “My Story” series, Friends President & CEO, Jeff Allen, PhD, recounts his personal experience with cancer from a young age when his grandfather was sick with the disease and why he is motivated for working in this field. With a background in cancer research focused upon...
Back to Top